by MEGIN | Oct 6, 2022 | Epilepsy, MEGIN News
In this webinar, viewers will learn how MEG is a key part of the epilepsy surgery evaluation, including information about the basics and safety of a MEG study, and hear about how MEG can help the surgeon by mapping key functions (speech, motor, and vision) onto their...
by MEGIN | Sep 14, 2022 | MEGIN News
MEGIN is delighted to be among the delegates of leading UK innovators heading to California this week (12-16 September 2022) as part of ABHI’s mission to bolster trade partnerships and promote the strengths of UK HealthTech stateside. The visit builds on the successes...
by MEGIN | Jul 25, 2022 | MEGIN News
This month, MEGIN is delighted to be among the delegate of leading UK HealthTech innovators heading to Tennessee to strengthen trade links and showcase their products and services to the US market. The visit marks the second major US trade mission organised this year...
by MEGIN | Mar 22, 2022 | MEGIN News
MEGIN is excited to be among the delegate of pioneering HealthTech companies heading to Texas as part of the first major US trade mission organized by the Association of British HealthTech Industries (ABHI) since the COVID-19 pandemic. The visit marks the launch of a...
by MEGIN | Feb 28, 2022 | MEGIN News
HELSINKI, FINLAND (March 07, 2022) – MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, by the University of Nebraska Medical Center (UNMC). UNMC scientists and clinicians are at the...
by MEGIN | Feb 18, 2022 | MEGIN News
It’s a first in Switzerland: the Human Neuroscience Platform (HNP) now hosts a magnetoencephalography (MEG) facility with the purchase of a MEGIN TRIUX™ neo, a state-of-the-art scanner that allows non-invasive analysis of brain activity. This acquisition is the result...
